Active or passive bio-coating: Does it matters in extracorporeal circulation?

Perfusion

Volumn 26, Issue 6, 2011, Pages 496-502

  Jacobs, S ^a   De Somer, F ^a   Vandenplas, G ^a   Van Belleghem, Y ^a   Taeymans, Y ^a   Van Nooten, G ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

CABG; cardiopulmonary bypass; heparin; inflammatory response; phosphorylcholine

Indexed keywords

HEPARIN; INTERLEUKIN 10; INTERLEUKIN 6; PHOSPHORYLCHOLINE; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; AORTA CLAMPING; ARTICLE; BIOFILTER; BLEEDING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG COATING; EXTRACORPOREAL CIRCULATION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOLYSIS; HUMAN; MALE; OXYGENATOR; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

AGED; CARDIOPULMONARY BYPASS; COATED MATERIALS, BIOCOMPATIBLE; COMPLEMENT ACTIVATION; CORONARY ARTERY BYPASS; FEMALE; HEMOLYSIS; HEPARIN; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; OXYGENATORS; PHOSPHORYLCHOLINE; PROSPECTIVE STUDIES;

EID: 80155172580     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659111415146     Document Type: Article

References (17)

1. Courtney JM, Zhao XB, Qian H, Sharma A. Modification of polymer surfaces: optimization of approaches. Perfusion. 2003 ; 18 (Suppl 1). 33-39 (Pubitemid 36503927)
2. Daniel S. Review on the multifactorial aspects of bioincompatibility in CPB. Perfusion. 1996 May ; 11 (3). 246-255 (Pubitemid 26338371)
3. Aldea GS, Soltow LO, Chandler WL, et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg. 2002 ; 123 (4). 742-755 (Pubitemid 34535085)
4. De Somer F, Van Belleghaem Y, Caes F, et al. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2002 ; 123 (5). 951-958
5. De Somer F, Van Belleghem Y, Caes F, et al. Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass. Perfusion. 2002 ; 17 (1). 39-44 (Pubitemid 34071706)
6. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular haemolysis and extracellular plasma haemoglobin: a novel mechanism of human disease. JAMA. 2005 ; 293 (13). 1653-1662 (Pubitemid 40471796)
7. Minneci PC, Deans KJ, Zhi H, et al. Haemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhaemoglobin. J Clin Invest. 2005 ; 115 (12). 3409-3417 (Pubitemid 43121829)
8. Day JR, Landis RC, Taylor KM. Aprotinin and the protease-activated receptor 1 thrombin receptor: antithrombosis, inflammation, and stroke reduction. Semin Cardiothorac Vasc Anesth. 2006 ; 10 (2). 132-142 (Pubitemid 44257201)
9. Day JR, Taylor KM, Lidington EA, et al. Aprotinin inhibits proinflammatory activation of endothelial cells by thrombin through the protease-activated receptor 1. J Thorac Cardiovasc Surg. 2006 ; 131 (1). 21-27 (Pubitemid 43049779)
10. Gong J, Larsson R, Ekdahl KN, Mollnes TE, Nilsson U, Nilsson B. Tubing loops as a model for cardiopulmonary bypass circuits: both the biomaterial and the blood-gas phase interfaces induce complement activation in an in vitro model. J Clin Immunol. 1996 ; 16 (4). 222-229 (Pubitemid 26249187)
11. Habib RH, Zacharias A, Schwann TA, et al. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: implications on operative outcome. Crit Care Med. 2005 ; 33 (8). 1749-1756 (Pubitemid 41153700)
12. Habib RH, Zacharias A, Schwann TA, Riordan CJ. The independent effects of cardiopulmonary bypass hemodilutional anemia and transfusions on CABG outcomes. Eur J Cardiothorac Surg. 2005 ; 28 (3). 512-513
13. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Adverse effects of low haematocrit during cardiopulmonary bypass in the adult: should current practice be changed?. J Thorac Cardiovasc Surg. 2003 ; 125 (6). 1438-1450 (Pubitemid 36759247)
14. Karkouti K, Beattie WS, Wijeysundera DN, et al. Haemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg. 2005 ; 129 (2). 391-400 (Pubitemid 40169564)
15. Karkouti K, Djaiani G, Borger MA, et al. Low haematocrit during cardiopulmonary bypass is associated with increased risk of perioperative stroke in cardiac surgery. Ann Thorac Surg. 2005 ; 80 (4). 1381-1387 (Pubitemid 41354124)
16. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Effects of obesity and small body size on operative and long-term outcomes of coronary artery bypass surgery: a propensity-matched analysis. Ann Thorac Surg. 2005 ; 79 (6). 1976-1986 (Pubitemid 40804173)
17. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Worse early outcomes in women after coronary artery bypass grafting: is it simply a matter of size?. J Thorac Cardiovasc Surg. 2004 ; 128 (3). 487-488 (Pubitemid 39194710)